NOS2 and neoplasm: Among the inhibitors tested, we reported that the pan-NOS inhibitor L-NMMA (NG-monomethyl-L-arginine) decreased cell proliferation, migration, and CSC self-renewal in vitro, and tumor growth (associated with less expression of Ki67), CSC self-renewal and tumor initiation in xenograft models of TNBC.